摘要
Increasing evidence indicates that c-mesenchymal-epithelial transition factor (cMET) plays an important role in the malignant progression of colorectal cancer (CRC). However, the underlying mechanism is not fully understood. As a metastasis suppressor, raf kinase inhibitory protein (RKIP) loss has been reported in many cancer types. In this study, the expression levels of cMET and RKIP in CRC tissues and cell lines were determined, and their crosstalk and potential biological effects were explored in vitro and in vivo. Our results showed that cMET was inversely correlated with RKIP. Both cMET upregulation and RKIP downregulation indicated poor clinical outcomes. Moreover, the MAPK/ERK signaling pathway was implicated in the regulation of cMET and RKIP. Overexpression of cMET promoted tumor cell epithelial-mesenchymal transition, invasion, migration, and chemoresistance, whereas the effects could be efficiently inhibited by increased RKIP. Notably, small hairpin RNA-mediated cMET knockdown dramatically suppressed cell proliferation, although no RKIP-induced influence on cell growth was observed in CRC. Altogether, cMET overexpression may contribute to tumor progression by inhibiting the antioncogene RKIP, providing preclinical justification for targeting RKIP to treat cMET-induced metastasis of CRC.
学科与关键词
- Effect of Raf kinase inhibitor protein expression on malignant biological behavior and progression of colorectal cancerWang Yun*; Wang Ling Yun; Feng Fen; Zhao Yang; Huang Ma Yan; Shao Qiong; Chen Cui; Sheng Hui; Chen Dong Liang; Zeng Zhao Lei; Xu Rui Hua; Li Yu HongOncology Reports, 2015, 34(4): 2106-2114.被引 1
- CircSTK3 drives the metastasis of colorectal cancer by regulating epithelial-mesenchymal transitionFan, Boyang*; Zheng, Chaojing; Wang, Ning; Chang, Zewen; Liu, Yunxiao; Wang, Chunlin; Xiang, Jun; Tao, Yangbao; Wang, Guiyu*; Zhang, Qian*iScience, 2023, 23(3): 106170.
- MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGF beta R1Xu Xuehu*; Chen Rong; Li Zhifa; Huang Nanqi; Wu Xiaobing; Li Shuling; Li Yong; Wu ShangbiaoBMC Cancer, 2015, 15: 1023.
